BHC Insider Trading

Insider Ownership Percentage: 3.31%
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$1,028,129.94

Bausch Health Companies Insider Trading History Chart

This chart shows the insider buying and selling history at Bausch Health Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bausch Health Companies Share Price & Price History

Current Price: C$10.83
Price Change: Price Increase of +0.47 (4.54%)
As of 03/21/2023 05:28 PM ET

This chart shows the closing price history over time for BHC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Bausch Health Companies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/14/2022Joseph PapaDirectorSell100,000C$9.84C$983,534.70934,594
4/14/2022Robert Allen SpurrSenior OfficerSell1,595C$27.96C$44,595.2424,617
3/15/2022Robert Allen SpurrSenior OfficerSell4,846C$28.42C$137,703.9426,212
8/4/2021Richard Urbain De SchutterDirectorBuy10,000C$33.02C$330,162.36280,857
5/26/2021Amy WechslerDirectorSell11,037C$41.96C$463,070.58
9/8/2020William Douglas HumphriesSenior OfficerSell5,667C$21.34C$120,958.71190,912
See Full Table

SEC Filings (Institutional Ownership Changes) for Bausch Health Companies (TSE:BHC)

81.73% of Bausch Health Companies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Bausch Health Companies logo
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Read More on Bausch Health Companies

Today's Range

Now: C$10.83
Low: C$10.50
High: C$11.01

50 Day Range

MA: C$11.11
Low: C$9.58
High: C$13.36

52 Week Range

Now: C$10.83
Low: C$5.10
High: C$30.43


497,724 shs

Average Volume

692,087 shs

Market Capitalization

C$3.92 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Bausch Health Companies?

Bausch Health Companies' top insider shareholders include:
  1. Joseph Papa (Director)
  2. Richard Urbain De Schutter (Director)
  3. Robert Allen Spurr (Senior Officer)
  4. Amy Wechsler (Director)
Learn More about top insider investors at Bausch Health Companies.